Examining the course of hallucinatory experiences in children and adolescents: A systematic review

Rubio, José M.; Sanjuán, Julio; Flórez‐Salamanca, Ludwing; Cuesta, Manuel J.

doi:10.1016/j.schres.2012.03.012

Cited by 69 publications

(50 citation statements)

References 41 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…Since EOP were reported to present a slightly different onset and clinical picture compared to adult-onset psychoses [2,6,18,27,37,88,90,94,115,108], early detection in children and adolescents might be confronted with additional challenges. This is supported by first reports on conversion rates in adolescent risk samples between age 12 and 18 [122,135], indicating that lag time to conversion might be longer and, consequently, conversion rates in the first years following initial risk assessment might be lower.…”

Section: Early Detection Of Psychoses In Children and Adolescentsmentioning

confidence: 99%

EPA guidance on the early detection of clinical high risk states of psychoses

et al. 2015

View full text Add to dashboard Cite

The aim of this guidance paper of the European Psychiatric Association is to provide evidence-based recommendations on the early detection of a clinical high risk (CHR) for psychosis in patients with mental problems. To this aim, we conducted a meta-analysis of studies reporting on conversion rates to psychosis in non-overlapping samples meeting any at least any one of the main CHR criteria: ultra-high risk (UHR) and/or basic symptoms criteria. Further, effects of potential moderators (different UHR criteria definitions, single UHR criteria and age) on conversion rates were examined. Conversion rates in the identified 42 samples with altogether more than 4000 CHR patients who had mainly been identified by UHR criteria and/or the basic symptom criterion 'cognitive disturbances' (COGDIS) showed considerable heterogeneity. While UHR criteria and COGDIS were related to similar conversion rates until 2-year follow-up, conversion rates of COGDIS were significantly higher thereafter. Differences in onset and frequency requirements of symptomatic UHR criteria or in their different consideration of functional decline, substance use and co-morbidity did not seem to impact on conversion rates. The 'genetic risk and functional decline' UHR criterion was rarely met and only showed an insignificant pooled sample effect. However, age significantly affected UHR conversion rates with lower rates in children and adolescents. Although more research into potential sources of heterogeneity in conversion rates is needed to facilitate improvement of CHR criteria, six evidence-based recommendations for an early detection of psychosis were developed as a basis for the EPA guidance on early intervention in CHR states.

show abstract

Section: Early Detection Of Psychoses In Children and Adolescentsmentioning

confidence: 99%

EPA guidance on the early detection of clinical high risk states of psychoses

et al. 2015

View full text Add to dashboard Cite

show abstract

“…Last, hallucinations that did not cause distress or impairment were substantially more common in the normal population. Rubio et al (2012) conducted a systematic review of 11 datasets, both epidemiological and clinical, to investigate the frequency of hallucinations in children and adolescents, as it is the period associated with the most hallucinatory experiences. In this review, the baseline prevalence of hallucinatory experiences ranged from 5 to 9% and 60-95% of individuals no longer had hallucinations over time.…”

Section: Hallucinations In Other Populationsmentioning

confidence: 99%

Twenty year multi-follow-up of different types of hallucinations in schizophrenia, schizoaffective disorder, bipolar disorder, and depression

Goghari

Harrow

2016

Schizophrenia Research

View full text Add to dashboard Cite

“…26,35,36,43 Although more data are needed on the longterm prognosis of hallucinations in childhood, recent reviews lean toward considering hallucinations in childhood as indicators of increased risk of adult psychiatric disorders. 44,45 At present, it is unclear if psychotic symptoms provoked by stimulant medication carry prognostic implications. In adults, it was found that psychosis induced by stimulants or cannabis abuse often persists or recurs in the absence of continued drug use.…”

Section: Discussionmentioning

confidence: 99%

Stimulant Medication and Psychotic Symptoms in Offspring of Parents With Mental Illness

et al. 2016

View full text Add to dashboard Cite

BACKGROUND: Stimulants, such as methylphenidate, are among the most commonly used medications in children and adolescents. Psychotic symptoms have been reported as rare adverse reactions to stimulants but have not been systematically inquired about in most previous studies. Family history of mental illness may increase the vulnerability to druginduced psychotic symptoms. We examined the association between stimulant use and psychotic symptoms in sons and daughters of parents with major mood and psychotic disorders.

show abstract

Examining the course of hallucinatory experiences in children and adolescents: A systematic review

Cited by 69 publications

References 41 publications

EPA guidance on the early detection of clinical high risk states of psychoses

EPA guidance on the early detection of clinical high risk states of psychoses

Twenty year multi-follow-up of different types of hallucinations in schizophrenia, schizoaffective disorder, bipolar disorder, and depression

Stimulant Medication and Psychotic Symptoms in Offspring of Parents With Mental Illness

Contact Info

Product

Resources

About